This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2006;5(3):289-94; discussion 295-6.

doi: 10.1007/s10689-005-5676-0.

The current status of chemoprevention in FAP

M H Wallace¹, P M Lynch

Affiliations

PMID: 16998675
DOI: 10.1007/s10689-005-5676-0

Review

The current status of chemoprevention in FAP

M H Wallace et al. Fam Cancer. 2006.

. 2006;5(3):289-94; discussion 295-6.

doi: 10.1007/s10689-005-5676-0.

Authors

M H Wallace¹, P M Lynch

Affiliation

¹ Department of Surgery, Watford General Hospital, Vicarage Road, WD18 0DH, Watford, UK. marina.wallace@whht.nhs.uk

PMID: 16998675
DOI: 10.1007/s10689-005-5676-0

No abstract available

PubMed Disclaimer

Similar articles

Chemoprevention of FAP with sulindac.
Meyskens FL Jr. Meyskens FL Jr. Curr Oncol Rep. 2002 Nov;4(6):463. doi: 10.1007/s11912-002-0061-8. Curr Oncol Rep. 2002. PMID: 12385292 Clinical Trial. No abstract available.
Efficacy and safety of eflornithine (CPP-1X)/sulindac combination therapy versus each as monotherapy in patients with familial adenomatous polyposis (FAP): design and rationale of a randomized, double-blind, Phase III trial.
Burke CA, Dekker E, Samadder NJ, Stoffel E, Cohen A. Burke CA, et al. BMC Gastroenterol. 2016 Aug 2;16(1):87. doi: 10.1186/s12876-016-0494-4. BMC Gastroenterol. 2016. PMID: 27480131 Free PMC article. Clinical Trial.
Assessing barriers to a rational chemoprevention trial design in young patients with familial adenomatous polyposis.
Wood JP, Howells LM, Brown K, Thomas AL. Wood JP, et al. Eur J Cancer Prev. 2017 Jul;26(4):277-284. doi: 10.1097/CEJ.0000000000000256. Eur J Cancer Prev. 2017. PMID: 27128580 Free PMC article.
[Familial adenomatous polyposis (FAP)--diagnosis and management].
Gondo N, Nakagawa K, Yanagi H, Yamamura T. Gondo N, et al. Gan To Kagaku Ryoho. 2002 Apr;29(4):532-8. Gan To Kagaku Ryoho. 2002. PMID: 11977536 Review. Japanese.
Celecoxib.
O'Rourke ME. O'Rourke ME. Clin J Oncol Nurs. 2000 May-Jun;4(3):143-4. Clin J Oncol Nurs. 2000. PMID: 11235255 Review. No abstract available.

See all similar articles

Cited by

Colorectal cancer chemoprevention: is this the future of colorectal cancer prevention?
Manzano A, Pérez-Segura P. Manzano A, et al. ScientificWorldJournal. 2012;2012:327341. doi: 10.1100/2012/327341. Epub 2012 Apr 29. ScientificWorldJournal. 2012. PMID: 22649288 Free PMC article. Review.
An intermittent approach for cancer chemoprevention.
Wu X, Lippman SM. Wu X, et al. Nat Rev Cancer. 2011 Nov 10;11(12):879-85. doi: 10.1038/nrc3167. Nat Rev Cancer. 2011. PMID: 22071977 Review.
Chemoprevention with special reference to inherited colorectal cancer.
Lynch PM. Lynch PM. Fam Cancer. 2008;7(1):59-64. doi: 10.1007/s10689-007-9158-4. Epub 2007 Aug 7. Fam Cancer. 2008. PMID: 17680350

References

1. J Surg Oncol. 1983 Sep;24(1):83-7 - PubMed
1. Dig Dis Sci. 2003 Oct;48(10):1998-2002 - PubMed
1. Lancet. 1995 Apr 1;345(8953):855-6 - PubMed
1. Int J Psychiatry Med. 1986-1987;16(3):211-30 - PubMed
1. Cancer Res. 1975 Nov;35(11 Pt. 2):3398-402 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Springer
Miscellaneous
- NCI CPTAC Assay Portal